These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31675664)

  • 1. Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease.
    Mancini M; Chung K; Zajack A; Martini DN; Ramsey K; Lapidus J; Horak FB; Nutt JG
    Parkinsonism Relat Disord; 2019 Dec; 69():40-47. PubMed ID: 31675664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of augmenting cholinergic function on gait and balance.
    Mancini M; Fling BW; Gendreau A; Lapidus J; Horak FB; Chung K; Nutt JG
    BMC Neurol; 2015 Dec; 15():264. PubMed ID: 26697847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.
    Chung KA; Lobb BM; Nutt JG; Horak FB
    Neurology; 2010 Oct; 75(14):1263-9. PubMed ID: 20810998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial.
    Vitorio R; Stuart S; Giritharan A; Quinn J; Nutt JG; Mancini M
    Parkinsonism Relat Disord; 2021 May; 86():10-14. PubMed ID: 33813359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy.
    Stuart S; Morris R; Giritharan A; Quinn J; Nutt JG; Mancini M
    Mov Disord; 2020 Nov; 35(11):2019-2027. PubMed ID: 32830901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
    Henderson EJ; Lord SR; Close JC; Lawrence AD; Whone A; Ben-Shlomo Y
    BMC Neurol; 2013 Dec; 13():188. PubMed ID: 24299497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
    Ravina B; Putt M; Siderowf A; Farrar JT; Gillespie M; Crawley A; Fernandez HH; Trieschmann MM; Reichwein S; Simuni T
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):934-9. PubMed ID: 15965198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.
    Neumann S; Taylor J; Bamford A; Metcalfe C; Gaunt DM; Whone A; Steeds D; Emmett SR; Hollingworth W; Ben-Shlomo Y; Henderson EJ
    BMC Neurol; 2021 Oct; 21(1):422. PubMed ID: 34715821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT
    Kucinski A; de Jong IE; Sarter M
    Eur J Neurosci; 2017 Jan; 45(2):217-231. PubMed ID: 27469080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease.
    Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
    Mov Disord; 2015 Sep; 30(10):1361-70. PubMed ID: 26095928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.
    Sawada H; Oeda T; Kohsaka M; Umemura A; Tomita S; Park K; Mizoguchi K; Matsuo H; Hasegawa K; Fujimura H; Sugiyama H; Nakamura M; Kikuchi S; Yamamoto K; Fukuda T; Ito S; Goto M; Kiyohara K; Kawamura T
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1332-1340. PubMed ID: 30076270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Henderson EJ; Lord SR; Brodie MA; Gaunt DM; Lawrence AD; Close JC; Whone AL; Ben-Shlomo Y
    Lancet Neurol; 2016 Mar; 15(3):249-58. PubMed ID: 26795874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.
    Aarsland D; Laake K; Larsen JP; Janvin C
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):708-12. PubMed ID: 12023410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial.
    Montero-Odasso M; Speechley M; Chertkow H; Sarquis-Adamson Y; Wells J; Borrie M; Vanderhaeghe L; Zou GY; Fraser S; Bherer L; Muir-Hunter SW
    Eur J Neurol; 2019 Apr; 26(4):651-659. PubMed ID: 30565793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of donepezil in gait disorders in eldery patients with dementia].
    Chebotareva AD; Dudchenko NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):56-59. PubMed ID: 31825391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.
    Ridha BH; Crutch S; Cutler D; Frost C; Knight W; Barker S; Epie N; Warrington EK; Kukkastenvehmas R; Douglas J; Rossor MN
    Alzheimers Res Ther; 2018 May; 10(1):44. PubMed ID: 29716655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α4β2
    Albin RL; Müller MLTM; Bohnen NI; Spino C; Sarter M; Koeppe RA; Szpara A; Kim K; Lustig C; Dauer WT
    Ann Neurol; 2021 Jul; 90(1):130-142. PubMed ID: 33977560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.